Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Application of Immunohistochemistry in the Classification of Salivary Gland Tumors (Part 4)

Continue reading
06 2 月

2019 USCAP | Meet You at MXB Booth 830

Continue reading
06 2 月

2018 National Symposium on Advances in Gynecological Pathology

Continue reading
06 2 月

New Use of Antibodies // Can NKX3.1 Be Used for Differential Diagnosis of Mesenchymal Chondrosarcoma?

Continue reading
06 2 月

Immunophenotypic Changes During B Lymphocyte Development

Continue reading
06 2 月

Meet the Official IP Characters of Maimai Mouse & Xinxin Rabbit | Download the Latest Pathological Emoji Pack Now!

Continue reading
06 2 月

The Role of FOXA1 Expression in Different Tumors

Continue reading
06 2 月

Common Equipment for Establishing an Immunohistochemistry Laboratory

Continue reading
06 2 月

Immunohistochemical Diagnosis of Renal Epithelial Tumors (Part 2)

Continue reading
06 2 月

Secretary Li Li of the National Medical Products Administration Visits Maixin for Research and Guidance

Continue reading
  • «
  • ‹
  • 42
  • 43
  • 44
  • 45
  • 46
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar